With BCG in short supply and recurrence rates still high, the race is on for better intravesical options. In this episode of BackTable Tumor Board, Dr. Lindsey Herrel, urologic oncologist at the University of Michigan, joins Dr. Ruchika Talwar to explore the evolving landscape of intravesical therapy for intermediate risk bladder cancer.

---

This podcast is supported by an educational grant from UroGen Pharma.

---

SYNPOSIS

The doctors break down the nuances of defining this risk category and the clinical gray zones that complicate treatment decisions. Dr. Herrell shares her patient-centered approach to surveillance and therapy, and introduces promising new agents, including Anktiva, UGN-102, and the gemcitabine-releasing TAR-200 "pretzel" device. The discussion also highlights how advances in molecular profiling are reshaping care strategies.
This episode underscores the urgent need for clearer guidelines and continued innovation to improve outcomes and quality of life for patients with this nuanced disease subtype.

---

TIMESTAMPS

00:00 - Introduction
02:03 - Defining Intermediate Risk Bladder Cancer
06:12 - Intravesical Therapy Options
08:47 - Quality of Life and Patient Counseling
10:18 - New Treatments on the Horizon
12:56 - Practical Tips for TURBT Recovery
17:03 - In-Office Procedure Management
21:38 - Managing Symptoms and Quality of Life
31:50 - A Note on Smoking Cessation
33:37 - Conclusion and Future Directions

Global medical missions bring unique challenges and powerful rewards—something Dr. Spencer Hiller and Dr. Kenneth Peters know firsthand. In this episode of BackTable Urology, they join host Dr. Jose Silva to reflect on their work in global health, focusing on their surgical missions to Zambia to treat complex urologic conditions, including vesicovaginal fistula, and a variety of general urologic cases.

---

SYNPOSIS

The discussion covers the origins and evolution of their missions, the preparation required for high-volume surgical trips, and the clinical impact on both patients and participating healthcare providers. Dr. Peters and Dr. Hiller detail the logistical and financial hurdles involved, the emphasis on sustainable care models, and their strategies for fundraising. They also emphasize the value of cultural immersion and the long-term goal of establishing educational and medical infrastructure within the communities they serve.

---

TIMESTAMPS

00:00 - Introduction
01:23 - The Mission to Africa: How It All Began
02:32 - Challenges and Logistics of Medical Missions
06:02 - Resident Involvement and Impact
09:10 - Preparation and Experiences in Africa
11:38 - Overcoming Obstacles: Supplies and Customs
19:18 - Types of Procedures and Medical Work in Africa
21:45 - Upgrading Equipment and Training Local Staff
28:28 - Daily Operations and Patient Management
31:00 - Post-Trip Activities and Community Engagement
34:26 - Funding and Sustainability Efforts
40:31 - Personal Reflections and Future Plans

Counseling patients with intermediate-risk non-muscle invasive bladder cancer can be complex, with a wide range of treatment options and care pathways. In this episode of BackTable Urology, urologic oncologists Dr. Ruchika Talwar and Dr. Kelly Bree explore how to approach this challenge with clarity and compassion.

---

This podcast is supported by an educational grant from UroGen Pharma.

---

SYNPOSIS

They emphasize a shift toward patient-centered, less aggressive treatment strategies, highlighting the importance of quality of life in clinical decision-making. The discussion includes risk stratification, the use of intravesical gemcitabine, and ongoing clinical trials. Dr. Bree also offers actionable tips for optimizing patient preparation and recovery. This episode underscores the growing importance of listening to patient voices to shape future standards of care.

---

TIMESTAMPS

00:00 - Introduction and Overview
02:09 - Risk Stratification and Treatment Approaches
06:12 - Intravesical Therapy Options
08:47 - Quality of Life and Patient Counseling
12:56 - Practical Tips for TURBT Recovery
17:03 - In-Office Procedures and Patient Management
21:23 - Resources and Support for Patients
24:13 - Future Directions and Final Thoughts

---

RESOURCES

Society of Urologic Oncology
https://suonet.org/home.aspx

This week, we present an inspiring episode for anyone interested in the history, present, and future of prostate cancer care. In this Legends in Urology installment of the BackTable Urology Podcast, Dr. Gerald Andriole joins guest host Dr. Niraj Badhiwala to reflect on a career that has left a lasting impact on the field.

---

SYNPOSIS

Dr. Andriole shares personal stories from his upbringing in Northeastern Pennsylvania and his journey into medicine. He reflects on his expedited education through Penn State and Jefferson Medical College and his path to urology. He discusses his pivotal work in prostate cancer screening, including the influence of major trials like The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, and traces the evolution of surgical and diagnostic techniques. The conversation also touches on current innovations and the future of prostate cancer management, offering valuable advice for the next generation of urologists.

---

TIMESTAMPS

00:00 - Introduction
01:59 - From Childhood to Medical School
06:48 - Discovering Urology
16:52 - Pioneering Prostate Cancer Screening
24:07 - The PLCO Study: Design and Challenges
28:57 - Controversies and Criticisms in Prostate Cancer Screening
33:29 - Evolving Practices in Prostate Cancer Management
44:19 - Future of Prostate Cancer Treatment

How do the experts balance organ preservation, oncologic control, and emerging therapies in both localized and metastatic cases of penile cancer? This episode of BackTable Tumor Board focuses on penile cancer diagnosis and treatment, featuring urologic oncologist Dr. Charles Peyton (UAB), radiation oncologist Dr. Juanita Crook (UBC), and medical oncologist Dr. Andrea Apolo (NCI).

---

This podcast is supported by:
Ferring Pharmaceuticals

---

SYNPOSIS

This session covers case studies ranging from localized to advanced penile cancer, diagnostic practices, imaging preferences (MRI vs. CT), and treatment options, including surgery, brachytherapy, chemoradiation, and neoadjuvant chemotherapy. The multidisciplinary team highlights the complexities of treating this rare cancer, underscores the importance of physical exams, and stresses the necessity of personalized treatment plans. They also delve into the challenges of managing metastatic stages, potential salvage therapies, and the importance of clinical trials in enhancing treatment efficacy. The doctors also emphasize the potential of immunotherapy and chemotherapy combinations for metastatic disease.

---

TIMESTAMPS

00:00 - Introduction
02:23 - Imaging Preferences
03:29 - Biopsy vs Immediate Surgery
06:04 - Lymph Node Dissection vs Radiation
13:48 - Brachytherapy Techniques and Case Study
23:21 - Challenges in Advanced Penile Cancer
27:03 - Chemotherapy and Chemoradiation
30:15 - InPACT Trial
37:12 - Salvage Therapies and Exploring New Treatment Frontiers
44:25 - Support and Awareness for Penile Cancer
51:29 - Final Thoughts

---

RESOURCES

Society of Urologic Oncology
https://suonet.org/home.aspx

Can we do more than prescribe pills to address men’s sexual health complaints? In this episode of the BackTable Urology Podcast, men’s health expert Dr. Mohit Khera from Baylor College of Medicine joins guest host Dr. Amy Pearlman for a deep dive into testosterone management and the full spectrum of erectile dysfunction therapies.

---

SYNPOSIS

The conversation covers daily tadalafil use, lifestyle optimization, and the nuanced role of off-label medications. Dr. Khera also highlights emerging technologies like the Tech Ring and radiofrequency treatments, alongside practical insights into semen analysis and hormonal health markers. Throughout, he emphasizes a holistic, patient-centered approach to sexual health—blending medical therapy with meaningful lifestyle change. This is a must-listen for general urologists, men’s health specialists, and trainees looking to expand their toolkit in this evolving field.

---

TIMESTAMPS

00:00 - Introduction
02:13 - Erectile Dysfunction and Testosterone
08:05 - Young Men's Health and Early Detection
10:20 - Semen Analysis for Overall Health
12:50 - Daily Tadalafil and Its Benefits
16:40 - Proactive Sexual Health Management
21:28 - Female Sexual Health
25:16 - Treating Delayed Ejaculation
28:53 - Psychogenic Erectile Dysfunction
31:16 - Technology in Sexual Health
35:54 - Lifestyle Modifications for Better Sexual Health
41:55 - Resources and Referrals for Patients
44:30 - Final Thoughts

With so many treatment modalities for upper tract urothelial carcinoma, how does new evidence inform optimal care? In this episode of BackTable Tumor Board, urologic oncologist Dr. Nirmish Singla (Johns Hopkins), medical oncologist Dr. Jeannie Hoffman-Censits (Johns Hopkins), and urologic oncologist Dr. Bogdana Schmidt discuss treatment and diagnosis of upper tract urothelial carcinoma (UTUC).

---

This podcast is supported by:

Ferring Pharmaceuticals
https://ad.doubleclick.net/ddm/trackclk/N2165306.5658203BACKTABLE/B33008413.420220578;dc_trk_aid=612466359;dc_trk_cid=234162109;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=;gdpr=${GDPR};gdpr_consent=${GDPR_CONSENT_755};gpp=${GPP_STRING_755};gpp_sid=${GPP_SID};ltd=;dc_tdv=1

---

SYNPOSIS

The discussion covers real-world UTUC cases, highlighting diagnostic challenges, treatment options, and evidence-based management strategies. They address scenarios ranging from localized to advanced UTUC, the role of systemic therapies, perioperative treatments, and the potential for novel approaches with immune checkpoint inhibitors. The episode underscores the evolving landscape of UTUC treatment and the importance of clinical trials and emerging biomarkers in improving patient outcomes.

---

TIMESTAMPS

00:00 - Introduction
02:49 - Case Study 1: 66-Year-Old Male with UTUC
11:19 - Case Study 2: 73-Year-Old Male with High-Grade Urothelial Carcinoma
28:11 - Intravesical Chemotherapy Protocols
30:44 - Case Study 3: 57-Year-Old Male with Recurrent Urothelial Cancer
41:25 Clinical Trials and Emerging Treatments
45:40 Case Study: 55-Year-Old Female with Bulky Lymphadenopathy
56:45 Concluding Remarks and Future Directions

---

RESOURCES

Society of Urologic Oncology
https://suonet.org/home.aspx

With fewer incisions and faster recovery, single port robotic surgery is changing the game—hear from the urologic surgeons leading the charge. This episode of BackTable Urology features an insightful discussion of the transformative impact of single port robotic surgery with Dr. Richard Link, Dr. Michael Stifelman and guest host Dr. Mihir Shah.

---

SYNPOSIS

This episode explores the benefits of single port (SP) robotic surgery, highlighting improved access, greater efficiency, and shorter patient recovery times. The doctors discuss the evolution of single port technology and the challenges that remain. They also share practical tips around case selection, building community support, and tracking outcomes to enhance efficacy. Whether you're new to SP or a seasoned surgeon, this episode offers valuable insights on how to refine your surgical practice.

---

TIMESTAMPS

00:00 - Introduction
04:18 - Early Adoption
06:50 - Commitment and Learning Curve
15:45 - Innovations and Best Practices
19:10 - The Magic of Single Port Access
29:29 - Practical Tips and Instrumentation
32:14 - Instrument Spread and Force Bipolar
34:25 - Benefits of Single-Port Surgery
35:57 - Challenges and Cognitive Load in SP Surgery
42:55 - Adoption and Resistance to SP Technology
50:52 - Final Thoughts

What if the key to better cancer outcomes lies not just in surgery or chemotherapy, but also in mindfulness, movement, and diet? In this episode of the BackTable Tumor Board, host Dr. Aditya Bagrodia interviews urologic oncologist Dr. Viraj Master, Professor of Urology at Emory University, about his role in developing the integrative oncology and survivorship service line at Winship Cancer Institute.

---

This podcast is supported by:

Ferring Pharmaceuticals

https://ad.doubleclick.net/ddm/trackclk/N2165306.5658203BACKTABLE/B33008413.420220578;dc_trk_aid=612466359;dc_trk_cid=234162109;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=;gdpr=${GDPR};gdpr_consent=${GDPR_CONSENT_755};gpp=${GPP_STRING_755};gpp_sid=${GPP_SID};ltd=;dc_tdv=1

---

SYNPOSIS

They discuss the evidence-based use of complementary therapies alongside conventional cancer treatments, touching on various integrative methods including diet, exercise, mindfulness, acupuncture, yoga, and supplements. Dr. Master emphasizes the importance of physicians being open to these practices and understanding their potential benefits for improving patient outcomes and quality of life, even in highly acute cases like muscle-invasive bladder cancer. The conversation covers the importance of honesty and understanding across patient journeys–from initial diagnosis to survivorship–highlighting the value of holistic approaches in cancer care.

---
TIMESTAMPS
00:00 - Integrative Oncology: Definitions and Basics
06:28 - Exercise and Its Impact on Cancer Treatment
08:12 - Physician Perspectives on Complementary Medicine
20:58 - Acupuncture and Acupressure in Cancer Care
25:28 - Practical Implementation of Integrative Approaches
31:30 - Supplements and Immuno Nutrition
36:25 - Cannabis, CBD, and Ayurveda in Cancer Care
44:39 - Conclusion and Final Thoughts

---

RESOURCES

Society of Urologic Oncology
https://suonet.org/home.aspx

Are you a resident considering a urology fellowship? How do you choose the right subspecialty, and how can effective mentorship help you make the right decision? In collaboration with the Society of Women in Urology (SWIU), this episode of BackTable Urology features practical fellowship advice from Dr. Sevann Helo of Mayo Clinic, Dr. Jay Simhan of Temple University, and guest host Dr. Helen Bernie of Indiana University.

---

SYNPOSIS

The three leaders in academic urology cover essential topics such as choosing the right fellowship program, finding strong mentorship, and balancing personal and professional life. This episode also offers transparency into the application process. The conversation also delves into the nebulous differences between ACGME and non-ACGME fellowships. This episode is an excellent starting point for practical advice for residents considering this pivotal step in their urology careers.

---

TIMESTAMPS

00:00 - Introduction
03:07 - Differences Between Residency and Fellowship
07:02 - Building a Competitive Fellowship Application
11:09 - Pros and Cons of Pursuing a Fellowship
16:08 - Accredited vs. Non-Accredited Fellowships
20:30 - Choosing the Right Fellowship Program
27:31 - Importance of Fellowship Fit
28:46 - Evaluating Candidates Beyond Portfolios
30:03 - Letters of Recommendation
34:56 - Handling Fellowship Challenges
38:28 - Gender Diversity in Urology
43:31 - Balancing Family and Fellowship
50:09 - Concluding Thoughts

---

RESOURCES

Society of Women in Urology
https://swiu.org/home.aspx